To ask the Secretary of State for Health and Social Care, if he will take steps to convene a roundtable of (a) pancreatic enzyme replacement therapy (PERT) manufacturers, (b) patient advocacy groups, (c) Government stakeholders and (d) other relevant stak
The Department currently has no plans to convene a roundtable regarding the shortages of pancreatic enzyme replacement therapy (PERT). The Department regularly engages with all suppliers of PERT to discuss the latest stock position and the steps that are ...
Pancreatic Enzyme Replacement Therapy